Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series


ABSTRACT: To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes. Comparative gene expression analysis of 14 M3, 62 other AML (M0, M1, M2 and M4) and 5 enriched normal promyelocyte samples revealed a signature of 1,121 genes that are specifically dysregulated in M3 samples relative to other AML, and that do not simply represent normal promyelocyte expression (â??M3-specific signatureâ??). We used a novel, high throughput digital platform (Nanostring's nCounter system) to evaluate a subset of the most significantly dysregulated genes in 30 AML samples; 33 of 37 evaluable gene expression patterns were validated. In an additional analysis, we selected only genes that are dysregulated in M3 both compared to other AML subtypes, and to purified normal CD34+ cells, promyelocytes, and/or neutrophils, thereby isolating a 478 gene "composite M3 dysregulome". Surprisingly, the expression of only a few of these genes was significantly altered in PR-9 cells after PML-RARA induction, suggesting that most of these genes are not direct targets of PML-RARA. Comparison of the M3-specific signature to our previously described murine APL dysregulome revealed 33 commonly dysregulated genes, including JUN, EGR1, and TNF. Collectively, these results suggest that PML-RARA initiates a transcriptional cascade which generates a unique downstream expression signature in both primary human and mouse APL cells. Experiment Overall Design: 14 human APL/M3 AML samples were compared to 62 AML samples of other AML FAB subtypes (bone marrow aspirates collected at diagnosis, included in GSE10358), to fractionated cells from normal human bone marrow aspirates (5 CD34+ cells, 5 promyelocytes, 5 neutrophils/PMNs), and to PR9 cells before and after Zinc-induction of PML-RARA.

ORGANISM(S): Homo sapiens

SUBMITTER: Jacqueline Payton 

PROVIDER: E-GEOD-12662 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples.

Payton Jacqueline E JE   Grieselhuber Nicole R NR   Chang Li-Wei LW   Murakami Mark M   Geiss Gary K GK   Link Daniel C DC   Nagarajan Rakesh R   Watson Mark A MA   Ley Timothy J TJ  

The Journal of clinical investigation 20090518 6


Acute promyelocytic leukemia (APL) is characterized by the t(15;17) chromosomal translocation, which results in fusion of the retinoic acid receptor alpha (RARA) gene to another gene, most commonly promyelocytic leukemia (PML). The resulting fusion protein, PML-RARA, initiates APL, which is a subtype (M3) of acute myeloid leukemia (AML). In this report, we identify a gene expression signature that is specific to M3 samples; it was not found in other AML subtypes and did not simply represent the  ...[more]

Similar Datasets

2008-09-06 | GSE12662 | GEO
2014-11-04 | E-GEOD-49344 | biostudies-arrayexpress
2017-05-12 | GSE90062 | GEO
2024-12-01 | GSE190341 | GEO
2010-12-29 | E-GEOD-26128 | biostudies-arrayexpress
2024-04-23 | GSE224815 | GEO
2024-04-23 | GSE224813 | GEO
2024-04-23 | GSE239350 | GEO
2010-12-30 | GSE26130 | GEO
2010-12-29 | GSE26128 | GEO